合成路线1
该中间体在本合成路线中的序号:
(I) Friedel-Crafts condensation of 4-bromophenol (I) with 1-adamantanol (II) in the presence of H2SO4 yielded the adamantyl phenol (III). Subsequent alkylation of the sodium phenoxide of (III) with iodomethane produced the methyl ether (IV). The Grignard reagent (V), prepared from aryl bromide (IV), was converted to the organozincate derivative, and then subjected to a nickel-catalyzed cross-coupling with methyl 6-bromo-2-naphthoate (VI) to furnish adduct (VII). The target carboxylic acid was finally obtained by saponification of the methyl ester (VII).
【1】
Charpentier, B.; et al.; Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes. J Med Chem 1995, 38, 26, 4993.
|
【2】
Shroot, B.; Eustache, J.; Bernardon, J.M. (Laboratoires Galderma SA); Benzonaphthalenic acid derivs., process for their preparation and their use in pharmacy and cosmetics. AU 9047961; EP 0199636; US 4717720; US 5098895; US 5183889 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25313 |
4-bromophenol
|
106-41-2 |
C6H5BrO |
详情 | 详情
|
(II) |
52642 |
1-Adamantanol; 1-Hydroxyadamantane; Tricyclo[3.3.1.1]decan-1-ol
|
768-95-6 |
C10H16O |
详情 | 详情
|
(III) |
59536 |
2-(1-adamantyl)-4-bromophenol
|
|
C16H19BrO |
详情 |
详情
|
(IV) |
59537 |
1-(5-bromo-2-methoxyphenyl)adamantane; 2-(1-adamantyl)-4-bromophenyl methyl ether
|
|
C17H21BrO |
详情 |
详情
|
(V) |
59538 |
[3-(1-adamantyl)-4-methoxyphenyl](bromo)magnesium
|
|
C17H21BrMgO |
详情 |
详情
|
(VI) |
59539 |
6-Bromo-2-naphthoic acid methyl ester; Methyl 6-bromo-2-naphthoate
|
33626-98-1 |
C12H9BrO2 |
详情 | 详情
|
(VII) |
59540 |
methyl 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoate
|
|
C29H30O3 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(II) The condensation of 4-chlorophenylsulfonate (I) with 4-bromophenol (II) by means of K2CO3 in hot DMF gives the aryl ether (III), which is condensed with piperazine (IV) by means of Pdo to yield the monosubstituted piperazine (V). Finally, this compound is condensed with the 4-bromophenyltriazolone (VI) by means of K2CO3 in hot DMSO to afford the target disubstituted piperazine
【1】
Hepperle, M.; Eckert, J.; Gala, D.; Shen, L.; Evans, C.A.; Goodman, A.; Mono N-arylation of piperazine(III): Metal-catalyzed N-arylation and its application to the novel preparations of the antifungal posaconazole and its advanced intermediate. Tetrahedron Lett 2002, 43, 18, 3359. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17109 |
[(3S,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furanyl]methyl 4-chlorobenzenesulfonate
|
|
C20H18ClF2N3O4S |
详情 |
详情
|
(II) |
25313 |
4-bromophenol
|
106-41-2 |
C6H5BrO |
详情 | 详情
|
(III) |
64328 |
1-{[(2R,4R)-4-[(4-bromophenoxy)methyl]-2-(2,4-difluorophenyl)tetrahydro-2-furanyl]methyl}-1H-1,2,4-triazole; 4-bromophenyl [(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furanyl]methyl ether
|
|
C20H18BrF2N3O2 |
详情 |
详情
|
(IV) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(V) |
64329 |
1-(4-{[(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furanyl]methoxy}phenyl)piperazine; [(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydro-3-furanyl]methyl 4-(1-piperazinyl)phenyl ether
|
|
C24H27F2N5O2 |
详情 |
详情
|
(VI) |
64326 |
2-[(1S,2S)-2-(benzyloxy)-1-ethylpropyl]-4-(4-bromophenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
|
|
C20H22BrN3O2 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(I) Treatment of 4-bromophenol (I) with phosphoryl chloride gave p-bromophenyl phosphoro- dichloridate (II), which was condensed with alanine methyl ester (III) to furnish alaninyl phosphorochloridate (IV). Further coupling of (IV) with 3'-azidothimidine (V) in the presence of N-methylimidazole afforded phosphate (VI). Then, addition of methyl hypobromite, (prepared from bromine and MeOH) provided the title compound as a diastereomeric mixture.
【1】
D'Cruz, O.; Jan, S.-T.; Shih, M.-J.; Chen, C.-L.; Uckun, F.M.; Venkatachalam, T.K.; Synthesis of dual function (5R,6R)- and (5S,6S)-5-bromo-6-methoxy-5,6-dihydro-AZT-5'-(para-bromophenyl methoxyalaninyl phosphate) as novel spermicidal and anti-HIV agents. Antivir Chem Chemother 1999, 10, 1, 39. |
【2】
Uckun, F.M.; Venkatachalam, T.; D'Cruz, O. (Parker Hughes Institute); AZT derivs. exhibiting spermicidal and anti-viral activity. WO 9948902 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25313 |
4-bromophenol
|
106-41-2 |
C6H5BrO |
详情 | 详情
|
(II) |
25314 |
Dichlorophoephoric acid 4-bromophenyl ester
|
|
C6H4BrCl2O2P |
详情 |
详情
|
(III) |
25315 |
methyl 2-aminopropanoate; Alanine, methyl ester
|
7625-53-8 |
C4H9NO2 |
详情 | 详情
|
(IV) |
25316 |
methyl 2-[[(4-bromophenoxy)(chloro)phosphoryl]amino]propanoate
|
|
C10H12BrClNO4P |
详情 |
详情
|
(V) |
25317 |
1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydro-2-furanyl]-5-methyl-2,4(1H,3H)-pyrimidinedione
|
101703-35-9 |
C10H13N5O4 |
详情 | 详情
|
(VI) |
25318 |
methyl 2-[[[((2S,3S,5R)-3-azido-5-[[(propionylamino)carbonyl]amino]tetrahydro-2-furanyl)methoxy](4-bromophenoxy)phosphoryl]amino]propanoate
|
|
C20H24BrN6O8P |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(I) 4-Bromophenol (I) was acetylated with Ac2O and Et3N, and the resulting 4-bromophenyl acetate (II) was rearranged to 5'-bromo-2'-hydroxyacetophenone (III) in the presence of AlCl3 at 120 C. Subsequent nitration of (III) produced the 3'-nitroacetophenone (IV). The catalytic hydrogenation of the nitro group of (IV), with simultaneous halogen hydrogenolysis, furnished 3'-amino-2'-hydroxyacetophe-none (V). Then, diazotization of the amine group of (V), followed by treatment with KI and Cu powder gave iodide (VI). Coupling of 4-phenyl-1-butanol (VII) with 4-hydroxybenzaldehyde (VIII) under Mitsunobu conditions provided 4-(4-phenylbutoxy)benzaldehyde (IX). Further Wittig reaction of (IX) with methylene triphenylphosphorane (X) gave the styrene (XI). This was condensed with the iodoacetophenone (VI) in the presence of Pd(OAc)2 to produce the stilbene derivative (XII). The benzopyranone (XIII) was prepared by condensation of hydroxyacetophenone (XII) with diethyl oxalate in the presence of NaOEt, followed by acid cyclization. After conversion of the ester function of (XIII) to the corresponding amide with methanolic ammonia, dehydration using POCl3 in DMF afforded nitrile (XIV). The required tetrazole ring was finally obtained by reaction with NaN3 and NH4Cl in DMF at 100 C.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25313 |
4-bromophenol
|
106-41-2 |
C6H5BrO |
详情 | 详情
|
(II) |
27286 |
4-bromophenyl acetate
|
|
C8H7BrO2 |
详情 |
详情
|
(III) |
27287 |
1-(5-bromo-2-hydroxyphenyl)-1-ethanone
|
1450-75-5 |
C8H7BrO2 |
详情 | 详情
|
(IV) |
27288 |
1-(5-bromo-2-hydroxy-3-nitrophenyl)-1-ethanone
|
|
C8H6BrNO4 |
详情 |
详情
|
(V) |
27289 |
1-(3-amino-2-hydroxyphenyl)-1-ethanone
|
|
C8H9NO2 |
详情 |
详情
|
(VI) |
27290 |
1-(2-hydroxy-3-iodophenyl)-1-ethanone
|
|
C8H7IO2 |
详情 |
详情
|
(VII) |
27291 |
4-phenyl-1-butanol
|
3360-41-6 |
C10H14O |
详情 | 详情
|
(VIII) |
13433 |
4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde
|
123-08-0 |
C7H6O2 |
详情 | 详情
|
(IX) |
27292 |
4-(4-phenylbutoxy)benzaldehyde
|
|
C17H18O2 |
详情 |
详情
|
(X) |
27301 |
methylene(triphenyl)phosphorane
|
|
C19H17P |
详情 |
详情
|
(XI) |
27293 |
1-(4-phenylbutoxy)-4-vinylbenzene
|
|
C18H20O |
详情 |
详情
|
(XII) |
27294 |
1-(2-hydroxy-3-[(E)-2-[4-(4-phenylbutoxy)phenyl]ethenyl]phenyl)-1-ethanone
|
|
C26H26O3 |
详情 |
详情
|
(XIII) |
27295 |
ethyl 4-oxo-8-[(E)-2-[4-(4-phenylbutoxy)phenyl]ethenyl]-4H-chromene-2-carboxylate
|
|
C30H28O5 |
详情 |
详情
|
(XIV) |
27296 |
4-oxo-8-[(E)-2-[4-(4-phenylbutoxy)phenyl]ethenyl]-4H-chromene-2-carbonitrile
|
|
C28H23NO3 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(IV) The intermediate phosphorochloridate (III) has been obtained as follows:
The reaction of 4-bromophenol (IV) with POCl3 and triethylamine in ethyl ether gives the corresponding phosphorodichloridate (V), which is finally condensed with L-alanine methyl ester (VI) by means of triethylamine in dichloromethane.
【1】
Uckun, F.M. (Parker Hughes Institute); Aryl phosphate derivatives of d4T having anti-HIV activity. WO 0000501 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III) |
32793 |
methyl (2S)-2-[[(4-bromophenoxy)(chloro)phosphoryl]amino]propanoate
|
|
C10H12BrClNO4P |
详情 |
详情
|
(IV) |
25313 |
4-bromophenol
|
106-41-2 |
C6H5BrO |
详情 | 详情
|
(V) |
25314 |
Dichlorophoephoric acid 4-bromophenyl ester
|
|
C6H4BrCl2O2P |
详情 |
详情
|
(VI) |
20694 |
methyl (2S)-2-aminopropanoate
|
|
C4H9NO2 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(I) Treatment of p-bromophenol (I) with phosphoryl chloride and triethylamine furnished p-bromophenyl phosphorodichloridate (II), which was condensed with alanine methyl ester (III) to give the intermediate phosphorochloridate (IV). Then, coupling of chloridate (IV) with azidothimidine (V) in the presence of N-methylimidazole yielded the title compound.
【1】
Venkatachalam, T.K.; Zhu, Z.; Shih, M.-J.; Tai, H.-L.; Uckun, F.M.; Jan, S.-T.; AZT-5'-(p-bromophenyl methoxyalaninyl phosphate) as a potent and non-toxic anti-human immunodeficiency virus agent. Antivir Chem Chemother 1999, 10, 1, 47.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25313 |
4-bromophenol
|
106-41-2 |
C6H5BrO |
详情 | 详情
|
(II) |
25314 |
Dichlorophoephoric acid 4-bromophenyl ester
|
|
C6H4BrCl2O2P |
详情 |
详情
|
(III) |
25315 |
methyl 2-aminopropanoate; Alanine, methyl ester
|
7625-53-8 |
C4H9NO2 |
详情 | 详情
|
(IV) |
25316 |
methyl 2-[[(4-bromophenoxy)(chloro)phosphoryl]amino]propanoate
|
|
C10H12BrClNO4P |
详情 |
详情
|
(V) |
25317 |
1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydro-2-furanyl]-5-methyl-2,4(1H,3H)-pyrimidinedione
|
101703-35-9 |
C10H13N5O4 |
详情 | 详情
|
合成路线7
该中间体在本合成路线中的序号:
(X) Condensation of 4-benzyloxybenzaldehyde (VI) with N,N-dimethylthioformamide in the presence of LDA in THF at -78 C provided the alpha-hydroxythioacetamide (VII), which was cyclized with methanesulfonic acid to yield benzothiophene (VIII). Subsequent acylation of (VIII) with the intermediate acid chloride (V) in boiling chlorobenzene provided ketone (IX). 4-Bromophenol (X) was protected as the triisopropylsilyl ether using triisopropylsilyl trifluoromethanesulfonate and imidazole, and then converted to the corresponding Grignard reagent (XI) with Mg in THF. Displacement of the dimethylamino group from benzothiophene (IX) by Grignard reagent (XI) furnished the 2-arylbenzothiophene (XII), which was desilylated with tetrabutylammonium fluoride to give (XIII). The ketone function of (XIII) was then reduced by means of LiAlH4 to yield (XIV).
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
31414 |
3-methoxy-4-(1-pyrrolidinylmethyl)benzoyl chloride
|
|
C13H16ClNO2 |
详情 |
详情
|
(VI) |
29179 |
4-(Benzyloxy)benzaldehyde
|
4397-53-9 |
C14H12O2 |
详情 | 详情
|
(VII) |
29181 |
2-[4-(benzyloxy)phenyl]-2-hydroxy-N,N-dimethylethanethioamide
|
|
C17H19NO2S |
详情 |
详情
|
(VIII) |
29182 |
6-(benzyloxy)-N,N-dimethyl-1-benzothiophen-2-amine
|
|
C17H17NOS |
详情 |
详情
|
(IX) |
31415 |
[6-(benzyloxy)-2-(dimethylamino)-1-benzothiophen-3-yl][3-methoxy-4-(1-pyrrolidinylmethyl)phenyl]methanone
|
|
C30H32N2O3S |
详情 |
详情
|
(X) |
25313 |
4-bromophenol
|
106-41-2 |
C6H5BrO |
详情 | 详情
|
(XI) |
31416 |
bromo[4-[(triisopropylsilyl)oxy]phenyl]magnesium
|
|
C15H25BrMgOSi |
详情 |
详情
|
(XII) |
31417 |
(6-(benzyloxy)-2-[4-[(triisopropylsilyl)oxy]phenyl]-1-benzothiophen-3-yl)[3-methoxy-4-(1-pyrrolidinylmethyl)phenyl]methanone
|
|
C43H51NO4SSi |
详情 |
详情
|
(XIII) |
31418 |
[6-(benzyloxy)-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl][3-methoxy-4-(1-pyrrolidinylmethyl)phenyl]methanone
|
|
C34H31NO4S |
详情 |
详情
|
(XIV) |
31419 |
4-[6-(benzyloxy)-3-[3-methoxy-4-(1-pyrrolidinylmethyl)benzyl]-1-benzothiophen-2-yl]phenol
|
|
C34H33NO3S |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(XI) The hydrolysis of 2-(dimethylamino)-6-methoxybenzo[b]thiophene (I) with HCl in refluxing THF gives 6-methoxybenzo[b]thiophen-2(3H)-one (II), which is condensed with 4-methoxybenzaldehyde (III) by means of piperidine in methanol yielding the 3-benzylidene derivative (IV). The rearrangement of (IV) with the same catalyst and solvent affords trans-6-methoxy-2-(4-methoxyphenyl)-2,3-dihydrobenzo[b]thiophene-3-carboxylic acid methyl ester (V), which is hydrolyzed with NaOH in methanol to the corresponding acid (VI). The reaction of (VI) with SOCl2 in dichloromethane gives the acyl chloride (VII), which is condensed with N,O-dimethylhydroxylamine by means of triethylamine in dichloromethane providing the N-methoxy-N-methylamide (VIII). The condensation of (VIII) with the Grignard reagent (IX) in THF affords the dimethyl ether of the target compound (X), which is finally demethylated with AlCl3 and propanethiol in dichloromethane.
The intermediate Grignard reagent (IX) has been obtained by condensation of 4-bromophenol (XI) with 1-(2-chloroethyl)piperidine (XII) by means of K2CO3 in hot DMF to give 1-[2-(4-bromophenoxy)ethyl]piperidine (XIII), which is then treated with magnesium in THF to afford (IX).
【1】
Stephenson, G.A.; Glasebrook, A.L.; Schmid, C.R.; Misner, J.W.; Synthesis and biological activity of trans-2,3-dihydroraloxifene. Bioorg Med Chem Lett 1999, 9, 8, 1137.
|
【2】
Glasebrook, A.L.; Schmid, C.R.; Stephenson, G.A.; Misner, J.W.; Synthesis and biological activity of dihydroraloxifene. 217th ACS Natl Meet (March 21 1999, Anaheim) 1999, Abst MEDI 072.
|
【3】
Misner, J.W.; Schmid, C.R. (Eli Lilly and Company); Intermediates and processes for preparing benzo[b]thiophenes. EP 0979076; WO 9848793 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
30906 |
N-(6-methoxy-1-benzothiophen-2-yl)-N,N-dimethylamine; 6-methoxy-N,N-dimethyl-1-benzothiophen-2-amine
|
|
C11H13NOS |
详情 |
详情
|
(II) |
30907 |
6-methoxy-1-benzothiophen-2(3H)-one
|
|
C9H8O2S |
详情 |
详情
|
(III) |
27251 |
4-methoxybenzaldehyde; Anisicaldehyde; p-anisaldehyde
|
123-11-5 |
C8H8O2 |
详情 | 详情
|
(IV) |
30908 |
6-methoxy-3-[(Z)-(4-methoxyphenyl)methylidene]-1-benzothiophen-2-one
|
|
C17H14O3S |
详情 |
详情
|
(V) |
30909 |
methyl (2R,3S)-6-methoxy-2-(4-methoxyphenyl)-2,3-dihydro-1-benzothiophene-3-carboxylate
|
|
C18H18O4S |
详情 |
详情
|
(VI) |
30910 |
(2R,3S)-6-methoxy-2-(4-methoxyphenyl)-2,3-dihydro-1-benzothiophene-3-carboxylic acid
|
|
C17H16O4S |
详情 |
详情
|
(VII) |
30911 |
(2R,3R)-6-methoxy-2-(4-methoxyphenyl)-2,3-dihydro-1-benzothiophene-3-carbonyl chloride
|
|
C17H15ClO3S |
详情 |
详情
|
(VIII) |
30912 |
(2R,3S)-N,6-dimethoxy-2-(4-methoxyphenyl)-N-methyl-2,3-dihydro-1-benzothiophene-3-carboxamide
|
|
C19H21NO4S |
详情 |
详情
|
(IX) |
30913 |
bromo[4-[2-(1-piperidinyl)ethoxy]phenyl]magnesium
|
|
C13H18BrMgNO |
详情 |
详情
|
(X) |
30914 |
[(2R,3S)-6-methoxy-2-(4-methoxyphenyl)-2,3-dihydro-1-benzothiophen-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone
|
|
C30H33NO4S |
详情 |
详情
|
(XI) |
25313 |
4-bromophenol
|
106-41-2 |
C6H5BrO |
详情 | 详情
|
(XII) |
10117 |
1-(2-Chloroethyl)piperidine; N-(2-Chloroethyl)piperidine
|
1932-03-2 |
C7H14ClN |
详情 | 详情
|
(XIII) |
30915 |
4-bromophenyl 2-(1-piperidinyl)ethyl ether; 1-[2-(4-bromophenoxy)ethyl]piperidine
|
|
C13H18BrNO |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(III) Treatment of 2-methyl-3-butyn-2-ol (I) with trifluoroacetic anhydride and DBU gave trifluoroacetate (II), which was condensed with 4-bromophenol (III) in the presence of CuCl2 to afford propargyl ether (IV). Cyclization of (IV) in N,N-diethylaniline at 185 C produced benzopyran (V). The required sulfonyl group was introduced in (V) by lithium-bromine exchange, followed by reaction with sulfur dioxide to give the lithium sulfinate (VI), and then oxidation to the sulfonyl chloride (VII) by means of sulfuryl chloride (1). Subsequent treatment of (VII) with diisobutylamine yielded sulfonamide (VIII). Asymmetric epoxidation of (VIII) using sodium hypochlorite and (S,S)(+)-N,N'-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamino-manganese(III) chloride (Jacobsen's catalyst) gave rise to epoxide (IX), which was opened with ammonium hydroxide to furnish the trans aminoalcohol (X). Finally, coupling of (X) with N-chlorophenyl-N'-cyanothiourea (XI) in the presence of EDC provided the title cyanoguanidine derivative.
【1】
Grover, G.J.; Ding, C.Z.; Miller, A.V.; Rovnyak, G.C.; Ahmed, S.Z.; Misra, R.N.; Normandin, D.E.; Atwal, K.S.; Kelly, Y.; Sleph, P.G.; Cardioselective antiischemic ATP-sensitive potassium channel (KATP) openers. 6. Effect of modifications at C6 of benzopyranyl cyanoguanidines. J Med Chem 1999, 42, 18, 3711. |
【2】
Ding, C.Z.; Atwal, K.S. (Bristol-Myers Squibb Co.); Sulfonamido substd. benzopyran potassium channel activators. CA 2178353; EP 0747374; JP 1997003035; US 5869478 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
33862 |
trifluoroacetic anhydride
|
407-25-0 |
C4F6O3 |
详情 | 详情
|
(I) |
17922 |
2-methyl-3-butyn-2-ol; 3-Methyl butynol
|
115-19-5 |
C5H8O |
详情 | 详情
|
(II) |
34888 |
1,1-dimethyl-2-propynyl 2,2,2-trifluoroacetate
|
|
C7H7F3O2 |
详情 |
详情
|
(III) |
25313 |
4-bromophenol
|
106-41-2 |
C6H5BrO |
详情 | 详情
|
(IV) |
34889 |
1-bromo-4-[(1,1-dimethyl-2-propynyl)oxy]benzene; 4-bromophenyl 1,1-dimethyl-2-propynyl ether
|
|
C11H11BrO |
详情 |
详情
|
(V) |
34890 |
6-bromo-2,2-dimethyl-2H-chromene
|
|
C11H11BrO |
详情 |
详情
|
(VI) |
34891 |
lithium 2,2-dimethyl-2H-chromene-6-sulfinate
|
|
C11H11LiO3S |
详情 |
详情
|
(VII) |
34892 |
2,2-dimethyl-2H-chromene-6-sulfonyl chloride
|
|
C11H11ClO3S |
详情 |
详情
|
(VIII) |
34893 |
N,N-diisobutyl-2,2-dimethyl-2H-chromene-6-sulfonamide
|
|
C19H29NO3S |
详情 |
详情
|
(IX) |
34894 |
(1aS,7bS)-N,N-diisobutyl-2,2-dimethyl-1a,7b-dihydro-2H-oxireno[2,3-c]chromene-6-sulfonamide
|
|
C19H29NO4S |
详情 |
详情
|
(X) |
34895 |
(3S,4R)-4-amino-3-hydroxy-N,N-diisobutyl-2,2-dimethyl-3,4-dihydro-2H-chromene-6-sulfonamide
|
|
C19H32N2O4S |
详情 |
详情
|
(XI) |
34896 |
N-(4-chlorophenyl)-N'-cyanothiourea
|
|
C8H6ClN3S |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(IV) The formylation of 3,5-dichloropyridine (I) with methyl formate (II), BuLi and DIEA in THF gives 3,5-dichloropyridine-4-carbaldehyde (III), which is treated with 4-bromophenol (IV) and potassium tert-butoxide in hot THF to yield the adduct (V). This compound, without isolation is cyclized with methyl 2-mercaptoacetate (VI) by means of Cs2CO3 to afford 4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylic acid methyl ester (VII), which is hydrolyzed with LiOH in THF/water to provide the corresponding carboxylic acid (VIII). Finally, this compound is condensed with methylamine (IX) by means of EDC and HOBt in DMF to give the target amide.
Alternatively, the target amide can also be obtained by direct reaction of methyl ester (VII) with methylamine (IX) in hot methanol in a sealed tube.
【1】
Zhu, G.-D.; et al.; Selective inhibition of ICAM-1 and E-selectin expression in human endothelial cells. 2. Aryl modifications of 4-(aryloxy)theino[2,3-c]pyridines with fine-tuning at C-2 carbamides. J Med Chem 2001, 44, 21, 3469.
|
【2】
Lartey, K.; Gunawardana, I.W.; Stout, D.M.; Bhatia, P.; Patel, M.V.; Staeger, M.A.; Boyd, S.A.; Mort, N.A.; Zhu, G.-D.; McCarty, C.M.; Stewart, A.O.; Arendsen, D.L.; Condroski, K.R.; Freeman, J.C. (Abbott Laboratories Inc.); Cell adhesion-inhibiting antiinflammatory cpds.. WO 9962908 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
35535 |
3,5-dichloropyridine
|
2457-47-8 |
C5H3Cl2N |
详情 | 详情
|
(II) |
45474 |
methyl formate
|
107-31-3 |
C2H4O2 |
详情 | 详情
|
(III) |
35536 |
3,5-dichloroisonicotinaldehyde; 3,5-Dichloropyridine-4-carbaldehyde |
136590-83-5 |
C6H3Cl2NO |
详情 | 详情
|
(IV) |
25313 |
4-bromophenol
|
106-41-2 |
C6H5BrO |
详情 | 详情
|
(V) |
52015 |
3-(4-bromophenoxy)-5-chloroisonicotinaldehyde
|
|
C12H7BrClNO2 |
详情 |
详情
|
(VI) |
18838 |
methyl 2-sulfanylacetate
|
2365-48-2 |
C3H6O2S |
详情 | 详情
|
(VII) |
52016 |
methyl 4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylate
|
|
C15H10BrNO3S |
详情 |
详情
|
(VIII) |
52017 |
4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylic acid
|
|
C14H8BrNO3S |
详情 |
详情
|
(IX) |
11021 |
Methanamine; Methylamine
|
74-89-5 |
CH5N |
详情 | 详情
|
合成路线11
该中间体在本合成路线中的序号:
(IV) The formylation of 3,5-dichloropyridine (I) with methyl formate (II), BuLi and DIEA in THF gives 3,5-dichloropyridine-4-carbaldehyde (III), which is treated with 4-bromophenol (IV) and potassium tert-butoxide in hot THF to yield the adduct (V). This compound, without isolation is cyclized with methyl 2-mercaptoacetate (VI) by means of Cs2CO3 to afford 4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylic acid methyl ester (VII), which is finally treated with hot methanolic ammonia in a sealed tube to give the target amide.
【1】
Zhu, G.-D.; et al.; Selective inhibition of ICAM-1 and E-selectin expression in human endothelial cells. 2. Aryl modifications of 4-(aryloxy)theino[2,3-c]pyridines with fine-tuning at C-2 carbamides. J Med Chem 2001, 44, 21, 3469.
|
【2】
Lartey, K.; Gunawardana, I.W.; Stout, D.M.; Bhatia, P.; Patel, M.V.; Staeger, M.A.; Boyd, S.A.; Mort, N.A.; Zhu, G.-D.; McCarty, C.M.; Stewart, A.O.; Arendsen, D.L.; Condroski, K.R.; Freeman, J.C. (Abbott Laboratories Inc.); Cell adhesion-inhibiting antiinflammatory cpds.. WO 9962908 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
35535 |
3,5-dichloropyridine
|
2457-47-8 |
C5H3Cl2N |
详情 | 详情
|
(II) |
45474 |
methyl formate
|
107-31-3 |
C2H4O2 |
详情 | 详情
|
(III) |
35536 |
3,5-dichloroisonicotinaldehyde; 3,5-Dichloropyridine-4-carbaldehyde |
136590-83-5 |
C6H3Cl2NO |
详情 | 详情
|
(IV) |
25313 |
4-bromophenol
|
106-41-2 |
C6H5BrO |
详情 | 详情
|
(V) |
52015 |
3-(4-bromophenoxy)-5-chloroisonicotinaldehyde
|
|
C12H7BrClNO2 |
详情 |
详情
|
(VI) |
18838 |
methyl 2-sulfanylacetate
|
2365-48-2 |
C3H6O2S |
详情 | 详情
|
(VII) |
52016 |
methyl 4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylate
|
|
C15H10BrNO3S |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(XII) Alternatively, intermediate (VI) can be obtained as follows: 1,4-Dichloro-2-butene (I) is condensed with p-bromophenol (XII) by means of Cs2CO3 in acetonitrile to give compound (XIII), which is then converted into acetate (XIV) after treatment with ammonium tetrabutyl acetate in refluxing acetone. Saponification of (XIV) with NaOH in MeOH affords alcohol (XV), which is then subjected to Claisen rearrangement by refluxing in ethyl orthoacetate in propionic acid to provide ester (XVI). Reduction of (XVI) with LiAlH4 Et2O gives alcohol (XVII), which is finally condensed with 4-bromophenyltributyl tin (XVIII) by means of Pd(PPh3)4 and LiCl in toluene.
【1】
Guilbaud, N.; Atassi, G.; Le Diguarher, T.; Bonnet, J.; Sabatini, M.; Casara, P.; Chollet, A.-M.; Pierre, A.; Tucker, G. (ADIR et Cie.); Carboxylic and hydroxamic acid cpds. inhibiting metalloproteases, method for preparing same and pharmaceutical compsns. containing them. EP 1091937; FR 2780402; WO 0000473 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
32186 |
(E)-1,4-dichloro-2-butene
|
110-57-6 |
C4H6Cl2 |
详情 | 详情
|
(VI) |
48857 |
ethyl 3-[[(4'-bromo[1,1'-biphenyl]-4-yl)oxy]methyl]-4-pentenoate
|
|
C20H21BrO3 |
详情 |
详情
|
(XII) |
25313 |
4-bromophenol
|
106-41-2 |
C6H5BrO |
详情 | 详情
|
(XIII) |
48862 |
1-bromo-4-[[(E)-4-chloro-2-butenyl]oxy]benzene; 4-bromophenyl (E)-4-chloro-2-butenyl ether
|
|
C10H10BrClO |
详情 |
详情
|
(XIV) |
48863 |
(E)-4-(4-bromophenoxy)-2-butenyl acetate
|
|
C12H13BrO3 |
详情 |
详情
|
(XV) |
48864 |
(E)-4-(4-bromophenoxy)-2-buten-1-ol
|
|
C10H11BrO2 |
详情 |
详情
|
(XVI) |
48865 |
ethyl 3-[(4-bromophenoxy)methyl]-4-pentenoate
|
|
C14H17BrO3 |
详情 |
详情
|
(XVII) |
48866 |
3-[(4-bromophenoxy)methyl]-4-penten-1-ol
|
|
C12H15BrO2 |
详情 |
详情
|
(XVIII) |
48867 |
(4-bromophenyl)(tributyl)stannane
|
|
C18H31BrSn |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(IV) The formylation of 3,5-dichloropyridine (I) with methyl formate (II), BuLi and DIEA in THF gives 3,5-dichloropyridine-4-carbaldehyde (III), which is treated with 4-bromophenol (IV) and potassium tert-butoxide in hot THF to yield the adduct (V). This compound, without isolation is cyclized with methyl 2-mercaptoacetate (VI) by means of Cs2CO3 to afford 4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylic acid methyl ester (VII), which is hydrolyzed with LiOH in THF/water to provide the corresponding carboxylic acid (VIII). Finally, this compound is condensed with ethanolamine (IX) by means of EDC and HOBt in DMF to give the target ethanolamide.
Alternatively, the target amide can also be obtained by direct reaction of methyl ester (VII) with ethanolamine (IX) in refluxing methanol.
【1】
Zhu, G.-D.; et al.; Selective inhibition of ICAM-1 and E-selectin expression in human endothelial cells. 2. Aryl modifications of 4-(aryloxy)theino[2,3-c]pyridines with fine-tuning at C-2 carbamides. J Med Chem 2001, 44, 21, 3469.
|
【2】
Lartey, K.; Gunawardana, I.W.; Stout, D.M.; Bhatia, P.; Patel, M.V.; Staeger, M.A.; Boyd, S.A.; Mort, N.A.; Zhu, G.-D.; McCarty, C.M.; Stewart, A.O.; Arendsen, D.L.; Condroski, K.R.; Freeman, J.C. (Abbott Laboratories Inc.); Cell adhesion-inhibiting antiinflammatory cpds.. WO 9962908 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
35535 |
3,5-dichloropyridine
|
2457-47-8 |
C5H3Cl2N |
详情 | 详情
|
(II) |
45474 |
methyl formate
|
107-31-3 |
C2H4O2 |
详情 | 详情
|
(III) |
35536 |
3,5-dichloroisonicotinaldehyde; 3,5-Dichloropyridine-4-carbaldehyde |
136590-83-5 |
C6H3Cl2NO |
详情 | 详情
|
(IV) |
25313 |
4-bromophenol
|
106-41-2 |
C6H5BrO |
详情 | 详情
|
(V) |
52015 |
3-(4-bromophenoxy)-5-chloroisonicotinaldehyde
|
|
C12H7BrClNO2 |
详情 |
详情
|
(VI) |
18838 |
methyl 2-sulfanylacetate
|
2365-48-2 |
C3H6O2S |
详情 | 详情
|
(VII) |
52016 |
methyl 4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylate
|
|
C15H10BrNO3S |
详情 |
详情
|
(VIII) |
52017 |
4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylic acid
|
|
C14H8BrNO3S |
详情 |
详情
|
(IX) |
13324 |
2-Methylaminoethanol; 2-(Methylamino)-1-ethanol
|
109-83-1 |
C3H9NO |
详情 | 详情
|
合成路线14
该中间体在本合成路线中的序号:
(I) Coupling between 4-bromophenol (I) and 1-adamantanol (II) in the presence of H2SO4 affords the adamantanyl phenol (III), which is further protected as the silyl ether (IV) by means of t-butyldimethylsilyl chloride and DMAP. Addition of triisopropyl borate to the organolithium derivative of (IV) gives rise, after aqueous quenching, to the boronic acid (V). Then, Suzuki coupling of boronic acid (V) with 6-bromopyridine-3-carbaldehyde (VI) furnishes the phenylpyridine adduct (VII). Desilylation of (VII) to provide phenol (VIII) is accomplished by treatment with tetrabutylammonium fluoride in THF. Finally, condensation of pyridine aldehyde (VIII) with 2,4-thiazolidinedione (IX) under Knoevenagel conditions provides the target compound
【1】
Spruce, L.W.; Pfahl, M.; Fanjul, A.; Tachdjian, C.; Al-Shamma, H.A.; Pleynet, D.P.M.; Wiemann, T.R.; Ibarra, J.B. (Maxia Pharmaceuticals, Inc.); Heterocyclic derivs. for the treatment of cancer and other proliferative diseases. WO 02/072009 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25313 |
4-bromophenol
|
106-41-2 |
C6H5BrO |
详情 | 详情
|
(II) |
52642 |
1-Adamantanol; 1-Hydroxyadamantane; Tricyclo[3.3.1.1]decan-1-ol
|
768-95-6 |
C10H16O |
详情 | 详情
|
(III) |
59536 |
2-(1-adamantyl)-4-bromophenol
|
|
C16H19BrO |
详情 |
详情
|
(IV) |
59537 |
1-(5-bromo-2-methoxyphenyl)adamantane; 2-(1-adamantyl)-4-bromophenyl methyl ether
|
|
C17H21BrO |
详情 |
详情
|
(V) |
61340 |
3-(1-adamantyl)-4-{[tert-butyl(dimethyl)silyl]oxy}phenylboronic acid
|
|
C22H35BO3Si |
详情 |
详情
|
(VI) |
61343 |
6-bromonicotinaldehyde
|
|
C6H4BrNO |
详情 |
详情
|
(VII) |
61341 |
6-(3-(1-adamantyl)-4-{[tert-butyl(dimethyl)silyl]oxy}phenyl)nicotinaldehyde
|
|
C28H37NO2Si |
详情 |
详情
|
(VIII) |
61342 |
6-[3-(1-adamantyl)-4-hydroxyphenyl]nicotinaldehyde
|
|
C22H23NO2 |
详情 |
详情
|
(IX) |
10883 |
1,3-Thiazolane-2,4-dione; 2,4-Thiazolidinedione
|
2295-31-0 |
C3H3NO2S |
详情 | 详情
|
合成路线15
该中间体在本合成路线中的序号:
(I)
【1】
Charugundla Kishore, Kumar Udhaya, Patil Rajendra Suryabhan. 2009. An improved process for the preparation of fesoterodine. WO 2009037569. |
【2】
Neela Praveen Kumar, Charugundla Kishore, Kumar Udhaya, et al. 2010. Fesoterodine substance of dehydroxy impurity. WO 2010010464. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25313 |
4-bromophenol
|
106-41-2 |
C6H5BrO |
详情 | 详情
|
(II) |
67138 |
6-bromo-4-phenylchroman-2-one |
156755-23-6 |
C15H11BrO2 |
详情 | 详情
|
(III) |
67139 |
methyl 3-(2-(benzyloxy)-5-bromophenyl)-3-phenylpropanoate |
|
C23H21BrO3 |
详情 | 详情
|
(IV) |
67140 |
3-(2-(benzyloxy)-5-bromophenyl)-3-phenylpropan-1-ol |
|
C22H21BrO2 |
详情 | 详情
|
(V) |
67141 |
3-(2-(benzyloxy)-5-bromophenyl)-3-phenylpropyl 4-methylbenzenesulfonate |
|
C29H27BrO4S |
详情 | 详情
|
(VI) |
67142 |
3-(2-(benzyloxy)-5-bromophenyl)-N,N-diisopropyl-3-phenylpropan-1-amine |
|
C28H34BrNO |
详情 | 详情
|
(VII) |
67143 |
(2S,3S)-2,3-bis((4-methylbenzoyl)oxy)succinic acid |
|
C20H18O8 |
详情 | 详情
|
(VIII) |
67144 |
(S)-3-(2-(benzyloxy)-5-bromophenyl)-N,N-diisopropyl-3-phenylpropan-1-amine (2S,3S)-2,3-bis((4-methylbenzoyl)oxy)succinate |
|
C28H34BrNO.C20H18O8 |
详情 | 详情
|
(IX) |
67145 |
(S)-3-(2-(benzyloxy)-5-bromophenyl)-N,N-diisopropyl-3-phenylpropan-1-amine |
|
C28H34BrNO |
详情 | 详情
|
(X) |
60854 |
4-(benzyloxy)-3-[(1R)-3-(diisopropylamino)-1-phenylpropyl]benzoic acid
|
|
C29H35NO3 |
详情 |
详情
|
(XI) |
60855 |
methyl 4-(benzyloxy)-3-[(1R)-3-(diisopropylamino)-1-phenylpropyl]benzoate
|
|
C30H37NO3 |
详情 |
详情
|
(XII) |
60856 |
{4-(benzyloxy)-3-[(1R)-3-(diisopropylamino)-1-phenylpropyl]phenyl}methanol
|
|
C29H37NO2 |
详情 |
详情
|
(XIII) |
60858 |
2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-(hydroxymethyl)phenol
|
|
C22H31NO2 |
详情 |
详情
|
(XV) |
67137 |
cinnamic acid |
140-10-3 |
C9H8O2 |
详情 | 详情
|
合成路线16
该中间体在本合成路线中的序号:
(XIV) Sharpless asymmetric epoxidation of β-methylallyl alcohol (XII) with cumene hydroperoxide (CMNOOH) in the presence of (i-PrO)4Ti and (+)-DET in toluene gives 2(S)-methylglycidyl alcohol (XIII), which by condensation with 4-bromophenol (XIV) by means of NaOH yields 3-(4-bromophenoxy)-2(R)-methylpropane-1,2-diol (XV). Buchwald-Hartwig coupling of aryl bromide (XV) with 4-[4-(trifluoromethoxy) phenoxy]piperidine (XVI) in the presence of Pd2(dba)3, t-BuONa and t-Bu XPhos in toluene affords adduct (XVII). Activation of the primary hydroxyl group in diol (XVII) with MsCl and Et3N in EtOAc followed by cyclization of the resulting hydroxy mesylate (XVIII) by means of K2CO3 in MeOH generates oxirane (XIX). Finally, epoxide (XIX) is condensed with 2-chloro-4-nitroimidazole (V) in the presence of NaOAc in t-BuOAc at 100 °C .
【1】
Yamamoto, A., Shinhama, K., Fujita, N. Aki, S., Ogasawara, S., Utsumi, N. (Otsuka Pharmaceutical Co., Ltd.). Synthetic intermediate of oxazole compound and method for producing the same. US 2012302757, WO 2011093529. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
67892 |
2-Chloro-4-nitroimidazole;2-Chloro-4-nitro-1H-imidazole |
57531-37-0 |
C3H2ClN3O2 |
详情 | 详情
|
(XII) |
43956 |
2-methyl-2-propen-1-ol
|
513-42-8 |
C4H8O |
详情 | 详情
|
(XIII) |
67899 |
2(S)-methylglycidyl alcohol |
|
C4H8O2 |
详情 | 详情
|
(XIV) |
25313 |
4-bromophenol
|
106-41-2 |
C6H5BrO |
详情 | 详情
|
(XV) |
67901 |
3-(4-bromophenoxy)-2(R)-methylpropane-1,2-diol |
|
C10H13BrO3 |
详情 | 详情
|
(XVI) |
67900 |
4-[4-(trifluoromethoxy)phenoxy]piperidine |
287952-67-4 |
C12H14F3NO2 |
详情 | 详情
|
(XVII) |
67904 |
(S)-2-methyl-3-(4-(4-(4-(trifluoromethoxy)phenoxy)piperidin-1-yl)phenoxy)propane-1,2-diol |
|
C22H26F3NO5 |
详情 | 详情
|
(XVIII) |
67903 |
(R)-2-hydroxy-2-methyl-3-(4-(4-(4-(trifluoromethoxy)phenoxy)piperidin-1-yl)phenoxy)propyl methanesulfonate |
|
C23H28F3NO7S |
详情 | 详情
|
(XIX) |
67902 |
(S)-1-(4-((2-methyloxiran-2-yl)methoxy)phenyl)-4-(4-(trifluoromethoxy)phenoxy)piperidine |
|
C22H24F3NO4 |
详情 | 详情
|